ClinicalTrials.gg
CompletedNCT04280445Updated Jan 1, 2025Results posted

Acceptance and Commitment Therapy for Older Adults

An interventional study of Psychological therapy in Psychological Distress, Anxiety and Depression, sponsored by University of Lincoln. Completed at 1 site in United Kingdom. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-01.

Primary conditionDepressionRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Depression
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Depression.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Lincoln · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
3
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Study summary

Title: Acceptance and Commitment Therapy for older adults experiencing psychological distress: A hermeneutic single case efficacy design (HSCED) series.

Anxiety and depression in older age is associated with increased level of disability and lower quality of life (OAs). Unfortunately, pharmacological treatments are disproportionality relied upon to manage the mental health of OAs. Despite cognitive behaviour therapy (CBT) being the recommended psychotherapy, there is evidence that CBT is less effective for OAs than younger populations.

An alternative treatment, Acceptance and Commitment Therapy (ACT), has been shown to be effective in reducing distress for OAs experiencing physical health difficulties. Several case studies have also indicated that ACT can be effective for OAs with psychological difficulties. ACT aims to change how a person interacts with their thoughts/feelings; to reduce avoidance; and to promote value-focused living.

The study aims to use an adjudicated HSCED to answer the following questions:

i) Is ACT an effective intervention for older adult clients experiencing psychological distress.

ii) Do meaningful changes occur for client-participants over the course of ACT intervention?

iii) What specific factors (ACT-specific, non-specific, extra-therapeutic) contribute to observed changes?

iv) Are observed changes broadly attributable to the ACT intervention?

v) What adaptations may facilitate change when using ACT with older adult clients.

For the study, up to four participants will be recruited from an OA community mental health team, each receiving up to 12 individual sessions of ACT. Participants will be required to complete a number of questionnaires throughout the study, including before/after sessions. Post-treatment, there will be a semi-structured 1:1 interview to explore any changes participants experienced, before a six-week follow-up is employed to check stability of change.

Read the detailed description

This study aims to investigate whether Acceptance and Commitment Therapy (ACT) is an effective psychotherapeutic intervention for older adults experiencing psychological distress; what processes contribute towards psychological change; and what adaptations may be required to optimise ACT for older adults. There is currently an over-reliance on pharmacological treatments to manage older adult mental health (Andreescu \& Reynolds, 2011), and a lack of inclusion of older adult in efficacy studies of psychological treatments (Gatz, 2006). Cognitive behaviour therapy (CBT) is the most evidence-based psychological treatment for mental health conditions. It emphasises the link between thoughts and feelings, and uses cognitive restructuring to facilitate improvement in psychological symptoms. However, of the studies that have included older adults, there is evidence that CBT has a lower effect size in older adults than with working age adults (Kishita \& Laidlaw, 2017). There are a number of possible reasons for this, including a lack of age specific adaptations, the over focus on diagnosis specific treatment protocols in CBT, and the increasing physical and psychological co-morbidity associated ageing.

ACT is a trans-diagnostic approach which aims to promote better living by supporting clients through six key processes (e.g. mindfulness, values). ACT does not aim to reduce distress, rather its goal is to promote better living or a better quality of life despite distress (Hayes, Strosahl \& Wilson, 1999). ACT has been shown to have equal or superior efficacy to CBT with a number of psychological and physical health conditions (A-Tjak et al., 2015; Ruiz, 2012). We propose that ACT would be especially suitable for older adult clients due to the high rate of co-morbidity older adults experience and the reduced ability to change aspects of these.

However, there is a lack of understanding about the processes by which ACT works (Öst, 2014). Randomised controlled trails (RCTs) are the standard research methodology to investigate psychotherapy efficacy. Due to the stringent criteria required for RCT analyses, there is a limit to how transferrable the findings of an RCT can be to clinical populations (i.e. heterogenous groups). As such, a hermeneutic single case efficacy design (HSCED) is an ideal methodology to employ to identify what contributes towards change for each client. HSCED benefits from high ecological validity, whilst actively focusing on non-specific factors (components common to all psychotherapies, e.g., therapeutic alliance) and extra-therapeutic factors (components that are not related to the therapy, usually participant factors) to delineate change processes.

The research proposal has been developed as part of a Doctoral Thesis in Clinical Psychology. This involved various research presentations panels and submission of an initial research protocol. These are designed to guide the decision-making process and gain feedback from the course research team. As part of the doctoral program, each trainee is allocated a Primary and Secondary Research Supervisor (both Clinical Psychologists), who aided in shaping the practicalities of this research proposal. Each project also recruits a Field Supervisor who supports with expertise in the project area. Participants will be recruited from the service the Field Supervisor is employed at, thereby creating a direct level of clinical supervision that is paramount to psychotherapy.

Participants will be informed about the study through a member of their healthcare team. The service will ensure potential participants have the capacity to consent to treatment and will provide them with an overview of the study. Potential participants will be made aware of informed consent; that they do not have to take part and that declining to take part will in no way affect their treatment from the service. If a participant declines to take part at this stage, they will be offered treatment as usual from the service. If they consent to take part, the researcher will contact them the following week to answer any additional questions. This will allow them sufficient time to consider whether they would like to take part or not.

This research aims to use a sample that is representative of older adults presenting with psychological distress. See Inclusion/Exclusion sections for further explanation of these criteria.

This study aims to reflect usual clinical practice where possible; therefore, the burden to participants will be of a similar level to treatment as usual. That is, they will be expected to attend the older adults service for regular one-to-one psychotherapy and to discuss their mental health difficulties, contributing factors and what is maintaining their difficulties. Thus, as with any psychological therapy, there is a potential risk that talking about distressing experiences will cause an increase in frequency or intensity of pre-existing mental health conditions. These risks will be monitored through the study by the Trainee Clinical Psychologist (who is both researcher and therapist) through discussion with the participant, use of outcome measures and importantly by utilising weekly clinical supervision with the Clinical Psychologist at the service. This allows a space for any concerns to be raised and for the service to have clinical oversight of the participants.

The aspects of the study which are additional to usual practice are as follows: participants will be required to complete more questionnaires; and participants will be required to come in for an interview after the block of therapy has ended. Every effort has been made to reduce the burden these place upon participants. For instance, shorter questionnaires have been used where possible. Participants will also be asked about any adaptations required to complete questionnaires (e.g. larger font, someone completing questionnaires with them). Participants will be reimbursed for the aspects of the study which are additional to usual practice.

There are several potential benefits to participants taking part in this research, as suggested by the ACT literature. These include decreased psychological distress, increased psychological flexibility and improved quality of life.

To ensure confidentiality, Participant Study Numbers (PSN) will be assigned to each participant to correspond with treatment data. PSNs will be listed in the Trial Recruitment Log along with participant's name, date of birth and NHS number. All other documents related to the participant will use the PSN only. All researchers will endeavour to protect the rights of the participants to privacy and will adhere to the Data Protection Act, 2018. Only the minimum required information for the purposes of the study will be collected. Participant information will be held securely, in a locked room, or locked cupboard or cabinet. Access to the information will be limited to the study staff and investigators. Computer held data including the study database will be held securely and password protected. All data will be stored on a secure dedicated web server. Access will be restricted by user identifiers and passwords (encrypted using a one-way encryption method). Information about the study in the participant's medical records / hospital notes will be treated confidentially in the same way as all other confidential medical information.

As the main researcher is also the therapist, potential conflict of interests will be managed by: using weekly clinical supervision; fortnightly ACT supervision; a 20% random sampling of the audio recorded sessions to ensure adherence to ACT techniques; and using an independent researcher to carry out the Change Interview. Another benefit of using a HSCED series, is that an independent panel adjudicates on the final outcome as to where change was attributed for each client, reducing the researcher-therapist bias.

02

Conditions studied

  • Psychological Distress
  • Anxiety
  • Depression

Browse trials for

Keywords

  • Aging
  • Acceptance and Commitment Therapy
  • Psychological distress
  • Anxiety
  • Depression
  • Hermeneutics
03

In context

Depression Reclassified

8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.

This study's enrollment of 3 is below the median of 81 across 7,063 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of Lincoln is the lead sponsor of 25 studies on the registry; 2 are open to participants now.

Compared within Depression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be at least 65 years of age.
  • Score at least 8 on the Hospital Anxiety and Depression Scale (HADS; ZIgmond \& Snaith, 1983) on either the anxiety or depression sub-scale. The HADS is an outcome measure already used by the MHSOP.
  • Be referred to the MHSOP for psychological support.
  • Have capacity to give .
  • Be willing to engage in one-to-one psychotherapy.
  • Be able to travel to the service (either independently or with support).

Exclusion criteria

Exclusion Criteria:

  • A score lower than 22-24 on the . This is to screen for a level of cognitive deficit, which cannot be accommodated for in the current study, due to the adaptations which will be required (e.g. review sessions, carer enrolment to support memory consolidation). Cut-off limit is dependent on the individual's age and education history. The MoCA is administered by the MHSOP as standard practice.
  • Not rated higher than Cluster 8 (Mental Health Clustering Booklet 2013/14, Department of Health), a categorisation based on the Health of the Nation Outcome Scale (HoNOS; Wing et al., 1998). Clusters higher than 8 are associated with clients presenting with symptoms of psychosis and it is felt that this level of mental health problem would cause serious heterogeneity between client cases. As standard practice, the MHSOP at Ling Bar Hospital will have rated the client prior to consideration for the study.
  • Inability to understand English to a level required to participate fully in the intervention. This is due to a lack of ability to benefit from the intervention without an interpreter, and the impact an interpreter would have on the non-therapeutic processes (e.g. alliance) being measured in this study.
  • Not currently undertaking any other psychological therapy, talking therapy or counselling. This is due to the potential impact the other therapy could have on change and the inability to fully account for this.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
3 participants (actual)

Study arms

  • Experimental
    Psychological therapy

    All participants will receive psychological therapy. There will be no placebos or waiting list controlled participants to compare findings to.

    Other: Psychological therapy

Interventions

  • OtherPsychological therapy

    Acceptance and Commitment Therapy (ACT) is a trans-diagnostic approach which aims to promote better living by supporting clients through six key processes (e.g. mindfulness, values). ACT does not aim to reduce distress, rather its goal is to promote better living or a better quality of life despite distress (Hayes, Strosahl \& Wilson, 1999). ACT has been shown to have equal or superior efficacy to CBT with a number of psychological and physical health conditions (A-Tjak et al., 2015; Ruiz, 2012).

    Also known as: Acceptance and Commitment Therapy

06

What researchers measure

Primary outcomes

  1. Change in Quality of Life Assessed Using the Older People's Quality of Life Questionnaire (OPQOL-brief).

    Brief measure of quality of life (QoL) in older age.

    Time frame: up to 20 weeks

Secondary outcomes

  1. Client's Level of Cognitive Functioning Assessed Using the Montreal Cognitive Assessment (MoCA).

    A brief cognitive screening questionnaire which will be administered by the usual care team at the start of the study.

    Time frame: up to 5 weeks

  2. Symptoms of Anxiety and Depression Assessed With the Hospital Anxiety and Depression Scale (HADS).

    A brief measure of anxiety and depression that is less prone to conflation of physical health symptoms onto symptoms of psychological distress.

    Time frame: up to 20 weeks

  3. Change in/Progress on Client's Goals Assessed Using the Simplified Personal Questionnaire (PQ).

    This consists of up to ten problem statements the client outlines at start of therapy and rates on a 7-point Likert scale for how much they have been bothered by the problem in the past week. They will then re-rate this before each therapy session and again at six-week follow-up.

    Time frame: up to 20 weeks

  4. Change in Client's Weekly Level of Quality of Life Assessed Using the Outcome Rating Scale (ORS).

    A brief measure of patient rated outcomes in therapy session.

    Time frame: up to 20 weeks

  5. Change in Therapeutic Alliance Assessed With the Session Rating Scale (SRS).

    A brief measure of patient rated therapeutic alliance.

    Time frame: up to 20 weeks

  6. Client's (Qualitative) Views on Individual Therapy Sessions Assessed With the Helpful Aspects of Therapy Form (HAT).

    A qualitative measure of patient rated therapeutic alliance.

    Time frame: up to 20 weeks

  7. Change in Psychological Flexibility Assessed Using the CompACT

    An ACT process measure.

    Time frame: up to 20 weeks

  8. Client's Attribution of Change and View on Therapy Assessed With the Change Interview

    A semi-structured interview to determine the participant's view on any change achieved during therapy. Delivered by a researcher other than the therapist.

    Time frame: up to 20 weeks

  9. Adherence to ACT Related Processes Assessed With the ACT Fidelity Measure (ACT-FM).

    A fidelity measure to ensure that sessions meet the requirements of ACT.

    Time frame: up to 20 weeks

07

Results

Posted Nov 2, 2021

Participant flow

Participant flow — Overall Study
MilestonePsychological Therapy
Started3
Completed3
Not completed0

Outcome measures

PrimaryChange in Quality of Life Assessed Using the Older People's Quality of Life Questionnaire (OPQOL-brief).

Brief measure of quality of life (QoL) in older age.

Time frame:
up to 20 weeks
Reported as:
Mean · score on a scale
Change in Quality of Life Assessed Using the Older People's Quality of Life Questionnaire (OPQOL-brief).
score on a scalePsychological Therapy
Change in Quality of Life Assessed Using the Older People's Quality of Life Questionnaire (OPQOL-brief).43.33 ± 8.39
SecondaryClient's Level of Cognitive Functioning Assessed Using the Montreal Cognitive Assessment (MoCA).

A brief cognitive screening questionnaire which will be administered by the usual care team at the start of the study.

Time frame:
up to 5 weeks

Results for this outcome have not been posted.

SecondarySymptoms of Anxiety and Depression Assessed With the Hospital Anxiety and Depression Scale (HADS).

A brief measure of anxiety and depression that is less prone to conflation of physical health symptoms onto symptoms of psychological distress.

Time frame:
up to 20 weeks

Results for this outcome have not been posted.

SecondaryChange in/Progress on Client's Goals Assessed Using the Simplified Personal Questionnaire (PQ).

This consists of up to ten problem statements the client outlines at start of therapy and rates on a 7-point Likert scale for how much they have been bothered by the problem in the past week. They will then re-rate this before each therapy session and again at six-week follow-up.

Time frame:
up to 20 weeks

Results for this outcome have not been posted.

SecondaryChange in Client's Weekly Level of Quality of Life Assessed Using the Outcome Rating Scale (ORS).

A brief measure of patient rated outcomes in therapy session.

Time frame:
up to 20 weeks

Results for this outcome have not been posted.

SecondaryChange in Therapeutic Alliance Assessed With the Session Rating Scale (SRS).

A brief measure of patient rated therapeutic alliance.

Time frame:
up to 20 weeks

Results for this outcome have not been posted.

SecondaryClient's (Qualitative) Views on Individual Therapy Sessions Assessed With the Helpful Aspects of Therapy Form (HAT).

A qualitative measure of patient rated therapeutic alliance.

Time frame:
up to 20 weeks

Results for this outcome have not been posted.

SecondaryChange in Psychological Flexibility Assessed Using the CompACT

An ACT process measure.

Time frame:
up to 20 weeks

Results for this outcome have not been posted.

SecondaryClient's Attribution of Change and View on Therapy Assessed With the Change Interview

A semi-structured interview to determine the participant's view on any change achieved during therapy. Delivered by a researcher other than the therapist.

Time frame:
up to 20 weeks

Results for this outcome have not been posted.

SecondaryAdherence to ACT Related Processes Assessed With the ACT Fidelity Measure (ACT-FM).

A fidelity measure to ensure that sessions meet the requirements of ACT.

Time frame:
up to 20 weeks

Results for this outcome have not been posted.

Adverse events

Collected over 6 months. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Psychological Therapy0/3 (0%)0/3 (0%)0/3 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Psychological Therapy
<=18 years0
Between 18 and 65 years0
>=65 years3
Age, Continuous
Age, Continuous(years)Psychological Therapy
Mean72.67 ± 5.86
Sex: Female, Male
Sex: Female, Male(Participants)Psychological Therapy
Female2
Male1
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Psychological Therapy
White British3
Older People's Quality of Life questionnaire, brief version (OPQOL-brief)
Older People's Quality of Life questionnaire, brief version (OPQOL-brief)(units on a scale)Psychological Therapy
Mean43.67 ± 7.57
Hospital Anxiety and Depression Scale - Anxiety Subscale(HADS-A)
Hospital Anxiety and Depression Scale - Anxiety Subscale(HADS-A)(units on a scale)Psychological Therapy
Mean13.67 ± 6.66
Hospital Anxiety and Depression Scale - Depression Subscale (HADS-D)
Hospital Anxiety and Depression Scale - Depression Subscale (HADS-D)(units on a scale)Psychological Therapy
Mean9.67 ± 3.06
Comprehensive Assessment of Acceptance and Commitment Therapy processes, short-form,(CompACT-8)
Comprehensive Assessment of Acceptance and Commitment Therapy processes, short-form,(CompACT-8)(units on a scale)Psychological Therapy
Mean20 ± 1.73
08

Study locations

1 site
  • Mental Health Services for Older People
    Nottingham, Nottinghamshire, United Kingdom
09

References and documents

Publications

  • Elliott R. Hermeneutic single-case efficacy design. Psychother Res. 2002 Mar 1;12(1):1-21. doi: 10.1080/713869614. PubMed 22471329 ↗
  • Hayes SC. Acceptance and commitment therapy: towards a unified model of behavior change. World Psychiatry. 2019 Jun;18(2):226-227. doi: 10.1002/wps.20626. No abstract available. PubMed 31059616 ↗
  • Ost LG. The efficacy of Acceptance and Commitment Therapy: an updated systematic review and meta-analysis. Behav Res Ther. 2014 Oct;61:105-21. doi: 10.1016/j.brat.2014.07.018. Epub 2014 Aug 19. PubMed 25193001 ↗
  • A-Tjak JG, Davis ML, Morina N, Powers MB, Smits JA, Emmelkamp PM. A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom. 2015;84(1):30-6. doi: 10.1159/000365764. Epub 2014 Dec 24. PubMed 25547522 ↗
  • Petkus AJ, M A, Wetherell JL. Acceptance and Commitment Therapy with Older Adults: Rationale and Considerations. Cogn Behav Pract. 2013 Feb;20(1):47-56. doi: 10.1016/j.cbpra.2011.07.004. PubMed 26997859 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Results will be written up in a peer-reviewed journal and as part of a Doctoral Thesis. Individual participant data will be anonymised. Should a request be made for individualised data, this would have to be approved by the various ethical and research boards involved.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04280445
Lead sponsor
University of Lincoln
Responsible party
Sponsor
First posted
Feb 21, 2020
Start date
Apr 29, 2020
Primary completion
Nov 18, 2020
Completion
Dec 18, 2020
Results posted
Nov 2, 2021
Last update
Jan 1, 2025

Study contacts

Nima Golijani-Moghaddam, Dr
principal investigator · University of Lincoln

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion